Tech Company Financing Transactions
Vilya Funding Round
On 8/30/2022, Vilya raised $50 million in Series A funding from Arch Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
8/30/2022
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
Arch Venture Partners (Lead Investor)
Proceeds Purpose
The funding will be used to advance the USA-based company's proprietary platform, powered by machine learning, which can be used to design molecular structures that range in size between small molecules and antibodies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Seattle, WA Undisclosed
USA
Seattle, WA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Robert Nelsen
Browse more venture capital transactions:
Prev: 8/30/2022: Aquaticode venture capital transaction
Next: 8/30/2022: Power venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs